This discussion by the European IP firm Carpmaels & Ransford provides an update on how the transfer of the right to claim priority is currently treated in Europe, including a discussion of the EPO’s recent CRISPR decision and its wider ramifications.
Questions? Inquiries about program materials? Contact Alan Johnson at ajohnson@bostonbar.org
Create your
podcast in
minutes
It is Free